Diphtheria Completed Phase 2 Trials for Streptococcus pneumoniae type 18c capsular polysaccharide antigen (DB10335)

Also known as: Corynebacterium diphtheriae infection / Infection due to Corynebacterium diphtheriae (disorder) / Diphtheria caused by Corynebacterium diphtheriae (disorder) / Diphtheria, unspecified

IndicationStatusPhase
DBCOND0000394 (Diphtheria)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01453998Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)Prevention
NCT01248884Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)Prevention
NCT01171989Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster DosePrevention
NCT01090453Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy InfantsPrevention